Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Antibody Fragments and Their Purification by Protein L Affinity Chromatography
KTH, School of Biotechnology (BIO), Industrial Biotechnology. JMVA Biotech, Sweden.
2015 (English)In: ANTIBODIES, ISSN 2073-4468, Vol. 4, no 3, 259-277 p.Article, review/survey (Refereed) Published
Abstract [en]

Antibodies and related proteins comprise one of the largest and fastest-growing classes of protein pharmaceuticals. A majority of such molecules are monoclonal antibodies; however, many new entities are antibody fragments. Due to their structural, physiological, and pharmacological properties, antibody fragments offer new biopharmaceutical opportunities. In the case of recombinant full-length antibodies with suitable Fc regions, two or three column purification processes centered around Protein A affinity chromatography have proven to be fast, efficient, robust, cost-effective, and scalable. Most antibody fragments lack Fc and suitable affinity for Protein A. Adapting proven antibody purification processes to antibody fragments demands different affinity chromatography. Such technology must offer the unit operation advantages noted above, and be suitable for most of the many different types of antibody fragments. Protein L affinity chromatography appears to fulfill these criteriasuggesting its consideration as a key unit operation in antibody fragment processing.

Place, publisher, year, edition, pages
MDPI AG , 2015. Vol. 4, no 3, 259-277 p.
Keyword [en]
affinity, antibody fragment, bioprocess, chromatography, monoclonal antibody, protein A, protein L
National Category
Immunology
Identifiers
URN: urn:nbn:se:kth:diva-177967DOI: 10.3390/antib4030259ISI: 000364227100007OAI: oai:DiVA.org:kth-177967DiVA: diva2:876353
Note

QC 20151203

Available from: 2015-12-03 Created: 2015-11-30 Last updated: 2015-12-03Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Van Alstine, James M.
By organisation
Industrial Biotechnology
Immunology

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 17 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf